Profil
Nathalie Riebel, formerly a Director of Clinical Operations at ImClone LLC, Director of Global Quality & Inspection at Eli Lilly & Co., Director of Clinical Operations at ICON plc, Director of Clinical Operations at GSK Plc, and currently serving as the Senior Vice President of Clinical Operations at PDS Biotechnology Corp.
Anciens postes connus de Nathalie Riebel
| Sociétés | Poste | Fin |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Directeur Technique/Scientifique/R&D | 01/12/2023 |
| ICON PUBLIC LIMITED COMPANY | Directeur Technique/Scientifique/R&D | 01/03/2011 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Directeur Technique/Scientifique/R&D | - |
| GSK PLC | Directeur Technique/Scientifique/R&D | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| GSK PLC | Health Technology |
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| Entreprise privées | 1 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |